Skip to main content
. 2010 May 4;588(Pt 13):2473–2486. doi: 10.1113/jphysiol.2010.188730

Figure 3.

Figure 3

Responses of peak activity of cardiac sympathetic afferents to repeated LA injection of ET-1 (2 μg) with vehicle (PBS, 1.5 ml, i.v., n= 7, A) or treatment with BQ-123 (0.1 mg kg−1, i.v., n= 9, B). C, neurohistograms of summated 2 s discharge activity from all nine cardiac afferents in response to ET-1 stimulation before (a) and after (b) treatment with BQ-123. Columns and error bars represent means ±s.e.m.*P < 0.05 compared with control. †P < 0.05 post-BQ-123 vs. pre-BQ-123.